IN186315B
(el)
*
|
1996-12-12 |
2001-08-04 |
Panacea Biotec Ltd |
|
EA002705B1
(ru)
*
|
1997-08-29 |
2002-08-29 |
Пфайзер Продактс Инк. |
Комбинационная терапия, включающая в себя амлодипин и статиновое соединение
|
GT199800127A
(es)
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
US20060141036A1
(en)
*
|
1997-12-12 |
2006-06-29 |
Andrx Labs Llc |
HMG-CoA reductase inhibitor extended release formulation
|
US5916595A
(en)
*
|
1997-12-12 |
1999-06-29 |
Andrx Pharmaceutials, Inc. |
HMG co-reductase inhibitor
|
EP0935964A1
(en)
*
|
1998-02-12 |
1999-08-18 |
Panacea Biotec Limited |
Pharmaceutical compositions containing NSAIDs and piperine
|
GB9812426D0
(en)
|
1998-06-10 |
1998-08-05 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
US6054585A
(en)
*
|
1998-12-23 |
2000-04-25 |
Sabinsa Corporation |
Process for making high purity piperine for nutritional use
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
AU768950B2
(en)
*
|
1999-11-08 |
2004-01-08 |
Andrx Corporation |
HMG-COA reductase inhibitor extended release formulation
|
IL141438A0
(en)
*
|
2000-02-23 |
2002-03-10 |
Pfizer Prod Inc |
Method of increasing the bioavailability and tissue penetration of azithromycin
|
DE10196213B4
(de)
*
|
2000-05-19 |
2020-12-17 |
Sabinsa Corp. |
Verwendung von Tetrahydropiperin zur Erhöhung der Bioverfügbarkeit von Nährstoffen und pharmazeutischen Präparationen
|
AP2002002453A0
(en)
*
|
2000-06-28 |
2002-06-30 |
Bakulesh Mafatlal Khamar |
Chemosensitizer
|
WO2002032400A1
(en)
*
|
2000-10-16 |
2002-04-25 |
Neopharm, Inc. |
Liposomal formulation of mitoxantrone
|
IT1320180B1
(it)
|
2000-12-29 |
2003-11-26 |
Hunza Di Marazzita Maria Carme |
Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
AU2003214505A1
(en)
*
|
2002-04-04 |
2003-10-20 |
Bakulesh Khamar |
Process for preparation of pharmaceutical composition containing antiretroviral protease inhibitor with improved bioavailability
|
US20070249537A1
(en)
*
|
2003-01-23 |
2007-10-25 |
Supernus Pharmaceuticals, Inc. |
Absorption enhancing agents
|
CN100425236C
(zh)
*
|
2003-03-31 |
2008-10-15 |
科学与工业研究委员会 |
孜然芹提取物与胡椒碱在制备强化抗感染剂的生物效力的药物中的用途
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
EP2011495A1
(en)
*
|
2007-07-03 |
2009-01-07 |
Sygnis Bioscience GmbH & Co. KG |
Use of piperine and derivatives thereof for the therapy of neurological conditions
|
US20090297622A1
(en)
*
|
2008-01-01 |
2009-12-03 |
Khorshid Faten A |
Separation and formulation of bioactive fraction and subfraction from camel urine work as anticancer agent
|
ES2547466T3
(es)
|
2009-06-17 |
2015-10-06 |
Fatin A. Khorshid |
Separación y formulación de fracción bioactiva y trabajo de subfracción de orina de camello como agente anticáncer
|
DK2804587T3
(da)
|
2012-01-19 |
2019-08-12 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Formulering og fremgangsmåde til øgning af lægemidlers biotilgængelighed
|
WO2019038454A1
(en)
*
|
2017-08-25 |
2019-02-28 |
Brilliantiq Ab |
FUNCTIONAL CHEMICAL GUM COMPRISING PHYTONUTRIMENTS AND ADAPTOGENIC HERBS
|
WO2019058386A1
(en)
|
2017-09-19 |
2019-03-28 |
Cipla Limited |
COMPOSITIONS COMPRISING IBRUTINIB AND AN ALKALOID HAVING IMPROVED BIOAVAILABILITY
|